Ublituximab significantly improves patient-reported outcomes: results from the phase 4 observational study ENABLE By Sheena Cruz / 05/26/2026
Real-world Clinical Experience from ENABLE, the First Phase 4 Observational Study for Patients with Relapsing Multiple Sclerosis Initiating Ublituximab By Sheena Cruz / 04/21/2026
Real-World Infusion Experience with Ublituximab in ENABLE, the Phase 4 Observational Study By admin / 02/06/2026
Real world clinical experience from ENABLE, the first Phase 4 observational study for patients with relapsing multiple sclerosis initiating ublituximab By admin / 09/24/2025
